Characterization and in vitro evaluation of a vaginal gel containing Lactobacillus crispatus for the prevention of gonorrhea
- 5 August 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 588, 119733
- https://doi.org/10.1016/j.ijpharm.2020.119733
Abstract
No abstract availableFunding Information
- Université Paris-Saclay
- Institut de Recherche pour le Développement
This publication has 62 references indexed in Scilit:
- Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the MicrobiotaPLOS ONE, 2013
- Alginate: Properties and biomedical applicationsProgress in Polymer Science, 2012
- Randomized, Placebo-Controlled Phase 2 Trial of a Lactobacillus crispatus Probiotic Given Intravaginally for Prevention of Recurrent Urinary Tract InfectionClinical Infectious Diseases, 2011
- The role of acidification in the inhibition of Neisseria gonorrhoeae by vaginal lactobacilli during anaerobic growthAnnals of Clinical Microbiology and Antimicrobials, 2011
- Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluidsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Vaginal microbiome of reproductive-age womenProceedings of the National Academy of Sciences of the United States of America, 2010
- Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microfloraBMC Microbiology, 2009
- Phase I Trial of aLactobacillus crispatusVaginal Suppository for Prevention of Recurrent Urinary Tract Infection in WomenInfectious Diseases in Obstetrics and Gynecology, 2007
- The Identification of VaginalLactobacillusSpecies and the Demographic and Microbiologic Characteristics of Women Colonized by These SpeciesThe Journal of Infectious Diseases, 1999
- Coaggregation of urogenital bacteria in vitro and in vivoCurrent Microbiology, 1990